April #69 : AAT Ease

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Geography Lessons

Mo' Money, Mo' Trouble

Cold Sore Comfort

THE BIZ OF AID$

Living Large on Small Change

Living Large on Small Change

Living Large on Small Change

O Pioneer!

Going Dental

Vax Attack

¡La Emergencia!

Monette & Merrill

Normal, New Jersey

Briefs

Milestones

Quickies

Money Pit

Cryptic 'Script

Don't Meth Around

AAT Ease

Two Strikes

LTNP? UB2

Is N-9 Deep-Sixed?

Action Zero

Mary MAC'd

Murphy's Law Breaker

Editor's Letter

Mailbox

04.09.84 The Waters of Babylon

Conflicts in Pharmaland



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

April 2001

AAT Ease

Wouldn't it be poetic justice if the blood in which HIV swims turned out to be the source of a ma

Wouldn't it be poetic justice if the blood in which HIV swims turned out to be the source of a major new weapon against it? That's what Leland Shapiro, MD, and a band of researchers at the University of Colorado Health Sciences Center in Denver have found. The trick comes in the form of alpha-1 antitrypsin (AAT), a blood protein that keeps HIV from reproducing and infecting healthy cells. When Shapiro & co. found that HIV does not grow in blood samples, their search for why led them to AAT, a natural inhibitor of serine proteases in the blood. Turns out the virus replicates like crazy in blood taken from people whose AAT levels are reduced due to a genetic defect. The researchers propose that although most people's bodies do contain the protein, HIV gets around it by reproducing in areas such as the lymph glands, where AAT levels are low. Researchers suggest two possible therapies: injections that might increase its level at the sites where HIV normally grows; and a synthetic serine protease inhibitor that mimics AAT's effects. New Jersey-based Cortech Inc. has developed it, and -- even easier to swallow -- their product might be useable in pill form. Preliminary but promising, the findings led scientists to call for more research into serine protease inhibitors. And that's where it's AAT for now.




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adorableone
    New York
    New York


    soy_Ric
    Rochester
    New York


    OahuAJ
    Turlock
    California


    HOTROD2010
    houston
    Texas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.